Paul Christine L, Ryan Annika, Rose Shiho, Attia John R, Kerr Erin, Koller Claudia, Levi Christopher R
The University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, 1/Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.
Implement Sci. 2016 Apr 8;11:51. doi: 10.1186/s13012-016-0414-6.
Thrombolysis using intravenous (IV) tissue plasminogen activator (tPA) is one of few evidence-based acute stroke treatments, yet achieving high rates of IV tPA delivery has been problematic. The 4.5-h treatment window, the complexity of determining eligibility criteria and the availability of expertise and required resources may impact on treatment rates, with barriers encountered at the levels of the individual clinician, the social context and the health system itself. The review aimed to describe health system factors associated with higher rates of IV tPA administration for ischemic stroke and to identify whether system-focussed interventions increased tPA rates for ischemic stroke.
Published original English-language research from four electronic databases spanning 1997-2014 was examined. Observational studies of the association between health system factors and tPA rates were described separately from studies of system-focussed intervention strategies aiming to increase tPA rates. Where study outcomes were sufficiently similar, a pooled meta-analysis of outcomes was conducted.
Forty-one articles met the inclusion criteria: 7 were methodologically rigorous interventions that met the Cochrane Collaboration Evidence for Practice and Organization of Care (EPOC) study design guidelines and 34 described observed associations between health system factors and rates of IV tPA. System-related factors generally associated with higher IV tPA rates were as follows: urban location, centralised or hub and spoke models, treatment by a neurologist/stroke nurse, in a neurology department/stroke unit or teaching hospital, being admitted by ambulance or mobile team and stroke-specific protocols. Results of the intervention studies suggest that telemedicine approaches did not consistently increase IV tPA rates. Quality improvement strategies appear able to provide modest increases in stroke thrombolysis (pooled odds ratio = 2.1, p = 0.05).
In order to improve IV tPA rates in acute stroke care, specific health system factors need to be targeted. Multi-component quality improvement approaches can improve IV tPA rates for stroke, although more thoughtfully designed and well-reported trials are required to safely increase rates of IV tPA to eligible stroke patients.
静脉注射组织型纤溶酶原激活剂(tPA)进行溶栓治疗是少数基于证据的急性卒中治疗方法之一,但实现高比例的静脉注射tPA给药一直存在问题。4.5小时的治疗窗口、确定资格标准的复杂性以及专业知识和所需资源的可用性可能会影响治疗率,在个体临床医生、社会环境和卫生系统本身等层面都会遇到障碍。本综述旨在描述与缺血性卒中静脉注射tPA给药率较高相关的卫生系统因素,并确定以系统为重点的干预措施是否能提高缺血性卒中的tPA给药率。
检索了1997年至2014年期间四个电子数据库中发表的英文原创研究。分别描述了卫生系统因素与tPA给药率之间关联的观察性研究以及旨在提高tPA给药率的以系统为重点的干预策略研究。当研究结果足够相似时,对结果进行汇总的荟萃分析。
41篇文章符合纳入标准:7篇是符合Cochrane协作实践证据和护理组织(EPOC)研究设计指南的方法学严谨的干预措施,34篇描述了卫生系统因素与静脉注射tPA给药率之间的观察到的关联。通常与较高静脉注射tPA给药率相关的系统相关因素如下:城市地区、集中式或中心辐射式模式、由神经科医生/卒中护士治疗、在神经科/卒中单元或教学医院、由救护车或移动团队收治以及卒中特定方案。干预研究结果表明,远程医疗方法并不能持续提高静脉注射tPA给药率。质量改进策略似乎能够适度提高卒中溶栓率(汇总比值比 = 2.1,p = 0.05)。
为了提高急性卒中护理中的静脉注射tPA给药率,需要针对特定的卫生系统因素。多成分质量改进方法可以提高卒中的静脉注射tPA给药率,尽管需要更精心设计和报告完善的试验来安全地提高符合条件的卒中患者的静脉注射tPA给药率。